Home > Income Statement > AUROBINDO PHARMA

AUROBINDO PHARMA
Income Statement

AUROBINDO PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for AUROBINDO PHARMA
Please provide your vote to see the results

AUROBINDO PHARMA Last 5 Year Income Statement History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
INCOME :
Gross Sales ₹63,559 Cr₹59,784 Cr₹50,860 Cr₹47,812 Cr₹48,590 Cr
     Sales ₹62,845 Cr₹59,006 Cr₹50,109 Cr₹47,481 Cr₹48,238 Cr
     Job Work/ Contract Receipts -----
     Processing Charges / Service Income ₹368 Cr₹481 Cr₹513 Cr₹242 Cr₹135 Cr
     Revenue from property development -----
     Other Operational Income ₹346 Cr₹297 Cr₹238 Cr₹89 Cr₹217 Cr
Less: Excise Duty -----
Net Sales ₹31,724 Cr₹29,002 Cr₹24,855 Cr₹23,455 Cr₹24,775 Cr
EXPENDITURE :
Increase/Decrease in Stock ₹-598 Cr₹-946 Cr₹-410 Cr₹817 Cr₹-730 Cr
Raw Material Consumed ₹12,270 Cr₹12,295 Cr₹10,600 Cr₹8,422 Cr₹9,558 Cr
     Opening Raw Materials ₹2,920 Cr₹2,681 Cr₹2,378 Cr₹3,028 Cr₹2,434 Cr
     Purchases Raw Materials ₹9,360 Cr₹9,762 Cr₹8,853 Cr₹5,817 Cr₹7,836 Cr
     Closing Raw Materials ₹2,904 Cr₹2,920 Cr₹2,681 Cr₹2,374 Cr₹3,028 Cr
     Other Direct Purchases / Brought in cost ₹2,887 Cr₹2,773 Cr₹2,050 Cr₹1,952 Cr₹2,315 Cr
     Other raw material cost ₹6.36 Cr₹-1.24 Cr---
Power & Fuel Cost ₹1,012 Cr₹826 Cr₹843 Cr₹627 Cr₹589 Cr
     Electricity & Power ₹1,012 Cr₹826 Cr₹843 Cr₹627 Cr₹589 Cr
     Oil, Fuel & Natural gas -----
     Coals etc -----
     Other power & fuel -----
Employee Cost ₹4,476 Cr₹3,923 Cr₹3,522 Cr₹3,451 Cr₹3,535 Cr
     Salaries, Wages & Bonus ₹3,925 Cr₹3,413 Cr₹3,073 Cr₹3,021 Cr₹3,070 Cr
     Contributions to EPF & Pension Funds ₹260 Cr₹228 Cr₹159 Cr₹150 Cr₹144 Cr
     Workmen and Staff Welfare Expenses ₹173 Cr₹184 Cr₹228 Cr₹213 Cr₹244 Cr
     Other Employees Cost ₹116 Cr₹97 Cr₹62 Cr₹66 Cr₹78 Cr
Other Manufacturing Expenses ₹3,556 Cr₹3,192 Cr₹2,810 Cr₹2,503 Cr₹2,875 Cr
     Sub-contracted / Out sourced services -----
     Processing Charges ₹69 Cr₹80 Cr₹36 Cr₹27 Cr₹65 Cr
     Repairs and Maintenance ₹518 Cr₹429 Cr₹384 Cr₹357 Cr₹336 Cr
     Packing Material Consumed ₹1,354 Cr₹1,254 Cr₹1,103 Cr₹901 Cr₹1,075 Cr
     Other Mfg Exp ₹1,616 Cr₹1,428 Cr₹1,287 Cr₹1,218 Cr₹1,400 Cr
General and Administration Expenses ₹1,552 Cr₹1,484 Cr₹1,387 Cr₹1,335 Cr₹1,474 Cr
     Rent , Rates & Taxes ₹166 Cr₹204 Cr₹242 Cr₹227 Cr₹212 Cr
     Insurance ₹138 Cr₹131 Cr₹121 Cr₹113 Cr₹89 Cr
     Printing and stationery ₹41 Cr₹36 Cr₹32 Cr₹32 Cr₹34 Cr
     Professional and legal fees ₹1,050 Cr₹979 Cr₹875 Cr₹872 Cr₹1,049 Cr
     Traveling and conveyance ₹117 Cr₹99 Cr₹82 Cr₹53 Cr₹47 Cr
     Other Administration ₹39 Cr₹36 Cr₹34 Cr₹38 Cr₹42 Cr
Selling and Distribution Expenses ₹2,185 Cr₹1,685 Cr₹1,686 Cr₹1,497 Cr₹1,564 Cr
     Advertisement & Sales Promotion -----
     Sales Commissions & Incentives ₹182 Cr₹155 Cr₹134 Cr₹280 Cr₹245 Cr
     Freight and Forwarding ₹1,136 Cr₹950 Cr₹1,087 Cr₹773 Cr₹838 Cr
     Handling and Clearing Charges -----
     Other Selling Expenses ₹867 Cr₹580 Cr₹465 Cr₹444 Cr₹481 Cr
Miscellaneous Expenses ₹688 Cr₹701 Cr₹699 Cr₹420 Cr₹576 Cr
     Bad debts /advances written off ₹13 Cr₹7.00 Cr---
     Provision for doubtful debts ₹5.39 Cr₹17 Cr₹52 Cr-₹28 Cr
     Losson disposal of fixed assets(net) ₹8.94 Cr₹51 Cr-₹40 Cr₹141 Cr
     Losson foreign exchange fluctuations ₹23 Cr-₹40 Cr--
     Losson sale of non-trade current investments -----
     Other Miscellaneous Expenses ₹638 Cr₹626 Cr₹607 Cr₹380 Cr₹407 Cr
Less: Expenses Capitalised -----
Total Expenditure ₹25,141 Cr₹23,159 Cr₹21,137 Cr₹19,071 Cr₹19,441 Cr
Operating Profit (Excl OI) ₹6,583 Cr₹5,843 Cr₹3,719 Cr₹4,385 Cr₹5,333 Cr
Other Income ₹622 Cr₹557 Cr₹291 Cr₹323 Cr₹381 Cr
     Interest Received ₹353 Cr₹286 Cr₹146 Cr₹32 Cr₹17 Cr
     Dividend Received ₹3.17 Cr₹2.54 Cr₹2.63 Cr₹3.37 Cr-
     Profit on sale of Fixed Assets -₹23 Cr₹13 Cr--
     Profits on sale of Investments ₹34 Cr₹0.10 Cr-₹29 Cr-
     Provision Written Back ₹12 Cr₹10 Cr₹13 Cr₹68 Cr₹83 Cr
     Foreign Exchange Gains -₹39 Cr-₹70 Cr₹104 Cr
     Others ₹220 Cr₹197 Cr₹116 Cr₹121 Cr₹178 Cr
Operating Profit ₹7,205 Cr₹6,400 Cr₹4,009 Cr₹4,707 Cr₹5,714 Cr
Interest ₹457 Cr₹290 Cr₹140 Cr₹49 Cr₹74 Cr
     InterestonDebenture / Bonds -----
     Interest on Term Loan -----
     Intereston Fixed deposits -----
     Bank Charges etc ₹17 Cr₹22 Cr₹12 Cr₹12 Cr₹15 Cr
     Other Interest ₹440 Cr₹268 Cr₹129 Cr₹37 Cr₹60 Cr
PBDT ₹6,747 Cr₹6,111 Cr₹3,869 Cr₹4,658 Cr₹5,640 Cr
Depreciation ₹1,649 Cr₹1,522 Cr₹1,245 Cr₹1,127 Cr₹1,055 Cr
Profit Before Taxation & Exceptional Items ₹5,098 Cr₹4,589 Cr₹2,624 Cr₹3,532 Cr₹4,584 Cr
Exceptional Income / Expenses -₹-192 Cr-₹-128 Cr₹2,815 Cr
Profit Before Tax ₹5,066 Cr₹4,380 Cr₹2,613 Cr₹3,373 Cr₹7,344 Cr
Provision for Tax ₹1,583 Cr₹1,211 Cr₹685 Cr₹726 Cr₹2,010 Cr
     Current Income Tax ₹1,700 Cr₹1,778 Cr₹1,071 Cr₹663 Cr₹2,322 Cr
     Deferred Tax ₹-117 Cr₹-567 Cr₹-387 Cr₹63 Cr₹-312 Cr
     Other taxes -----
Profit After Tax ₹3,484 Cr₹3,169 Cr₹1,928 Cr₹2,647 Cr₹5,334 Cr
Extra items -----
Minority Interest ₹2.31 Cr₹4.00 Cr₹-0.15 Cr₹1.04 Cr₹1.02 Cr
Share of Associate -----
Other Consolidated Items -----
Consolidated Net Profit ₹3,486 Cr₹3,173 Cr₹1,928 Cr₹2,648 Cr₹5,335 Cr
Adjustments to PAT -----
Profit Balance B/F ₹26,801 Cr₹23,910 Cr₹22,519 Cr₹20,137 Cr₹15,042 Cr
Appropriations ₹30,287 Cr₹27,083 Cr₹24,446 Cr₹22,785 Cr₹20,377 Cr
     General Reserves -----
     Proposed Equity Dividend -----
     Corporate dividend tax -----
     Other Appropriation ₹-198 Cr₹282 Cr₹360 Cr₹2.25 Cr₹6.10 Cr
Equity Dividend % -₹450.00₹300.00₹900.00₹400.00
Earnings Per Share ₹60.02₹54.16₹32.90₹45.20₹91.05
Adjusted EPS ₹60.02₹54.16₹32.90₹45.20₹91.05

Compare Income Statement of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹87,776.3 Cr 1.4% 12.7% 28.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹451,075.0 Cr 0.9% 12.8% 4.6% Stock Analytics
DIVIS LABORATORIES ₹179,486.0 Cr 3.2% 14% 13.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹149,124.0 Cr 0.7% 5.5% 36.9% Stock Analytics
CIPLA ₹115,641.0 Cr 6.8% 18.8% -10.2% Stock Analytics
DR REDDYS LABORATORIES ₹111,589.0 Cr 0.7% 5.5% 9.4% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

1.4%

12.7%

28.7%

SENSEX

-2.7%

-2.1%

-5.3%


You may also like the below Video Courses